RhumbLine Advisers’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-196,773
| Closed | -$787K | – | 2951 |
|
|
2019
Q4 | $787K | Buy |
196,773
+11,181
| +6% | +$52.5K | ﹤0.01% | 2184 |
|
|
2019
Q3 | $909K | Buy |
185,592
+11,779
| +7% | +$65.9K | ﹤0.01% | 2078 |
|
|
2019
Q2 | $1.06M | Buy |
173,813
+13,863
| +9% | +$73.7K | ﹤0.01% | 2049 |
|
|
2019
Q1 | $929K | Sell |
159,950
-1,486
| -0.9% | -$15.3K | ﹤0.01% | 2072 |
|
|
2018
Q4 | $2.17M | Buy |
161,436
+28,901
| +22% | +$487K | ﹤0.01% | 1593 |
|
|
2018
Q3 | $2.57M | Buy |
132,535
+8,606
| +7% | +$183K | 0.01% | 1522 |
|
|
2018
Q2 | $3.17M | Buy |
123,929
+7,800
| +7% | +$182K | 0.01% | 1402 |
|
|
2018
Q1 | $2.34M | Buy |
116,129
+2,803
| +2% | +$65.4K | ﹤0.01% | 1510 |
|
|
2017
Q4 | $2.27M | Buy |
113,326
+15,713
| +16% | +$309K | ﹤0.01% | 1555 |
|
|
2017
Q3 | $2.02M | Buy |
97,613
+4,925
| +5% | +$83.3K | ﹤0.01% | 1621 |
|
|
2017
Q2 | $1.37M | Buy |
92,688
+6,738
| +8% | +$112K | ﹤0.01% | 1778 |
|
|
2017
Q1 | $1.37M | Buy |
85,950
+24,076
| +39% | +$347K | ﹤0.01% | 1762 |
|
|
2016
Q4 | $780K | Buy |
61,874
+2,873
| +5% | +$53.5K | ﹤0.01% | 1988 |
|
|
2016
Q3 | $1.65M | Buy |
59,001
+6,775
| +13% | +$227K | ﹤0.01% | 1532 |
|
|
2016
Q2 | $1.83M | Buy |
52,226
+9,924
| +23% | +$312K | 0.01% | 1400 |
|
|
2016
Q1 | $1.16M | Buy |
42,302
+6,765
| +19% | +$199K | ﹤0.01% | 1696 |
|
|
2015
Q4 | $1.22M | Buy |
35,537
+3,550
| +11% | +$111K | ﹤0.01% | 1676 |
|
|
2015
Q3 | $919K | Buy |
31,987
+1,382
| +5% | +$59.1K | ﹤0.01% | 1821 |
|
|
2015
Q2 | $1.37M | Buy |
30,605
+19,405
| +173% | +$730K | ﹤0.01% | 1666 |
|
|
2015
Q1 | $387K | Buy |
11,200
+3,150
| +39% | +$85.7K | ﹤0.01% | 2455 |
|
|
2014
Q4 | $220K | Buy |
+8,050
| New | +$195K | ﹤0.01% | 2754 |
|
Other funds holding DPLO
RhumbLine Advisers's DPLO Position: Q1 2020 in Review
RhumbLine Advisers sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 196,773 shares — an estimated $787K sold.
RhumbLine Advisers first reported a position in DPLO in Q4 2014 and held it in 21 quarters. The position peaked at $3.17M in Q2 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- RhumbLine Advisers reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- RhumbLine Advisers sold 196,773 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $787K.
- RhumbLine Advisers first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 21 quarters.
- RhumbLine Advisers's DIPLOMAT PHARMACY, INC. position peaked at $3.17M in Q2 2018.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on RhumbLine Advisers's 13F filing for Q1 2020, filed 6 May 2020.